ZyVersa Therapeutics, Inc.
ZyVersa Therapeutics, Inc.
Your view on ZVSA
Overview
What the company does, where it operates, and who runs it.
About ZyVersa Therapeutics, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Stephen C. Glover
- Headquarters
- 2200 N. Commerce Parkway, Weston, FL, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Stephen C. Glover
- Headquarters
- 2200 N. Commerce Parkway, Weston, FL, US
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.